Halo Therapeutics stock drops following weak 2023 outlook

Halozyme Therapeutics Inc. HALO, -10.09% stock fell in the extended session Tuesday after the biotech drug maker’s 2023 forecast disappointed Wall Street. Halozyme shares fell as much as 8% after hour...

Delta, JPMorgan, BlackRock and more

Check out the companies making headlines before the bell: Delta Air Lines (DAL) – Delta rallied 6.6% in the premarket after reporting a smaller-than-expected quarterly loss and predicting a current-qu...